Skip to main content

Regulus Therapeutics Inc.

RGLSDelisted Jun 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001505512

Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Regulus Therapeutics Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of RGLS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders3728−9
SharesConverted for a 1-for-10 split6.07M6.07M+3.12K (+0.1%)
Value$18.1M$12.6M−$5.51M (−30.5%)

New holders (7)

Institutions that held Regulus Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RGLS in Q2 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC23,655$49.0K0.00%
Virtu Financial LLC10,205$21.0K0.00%
Acadian Asset Management LLC8,049$17.0K0.00%
Bank of America Corp1,001$2.00K0.00%
Simplex Trading, LLC527$1.00K0.00%
Citigroup Inc8$00.00%
Rockefeller Capital Management L.P.1$00.00%

Sold out (16)

Institutions that held Regulus Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RGLS in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Price T Rowe Associates Inc184,600$55.0K
Two Sigma Advisers, LP170,500$51.0K
Two Sigma Investments, LP114,440$34.0K
Grimes & Company, Inc.88,203$26.0K
Jane Street Group, LLC73,644$22.0K
WealthTrust Axiom LLC68,000$20.0K
Susquehanna International Group, LLP65,825$20.0K
Lido Advisors, LLC54,500$16.0K
Millennium Management LLC48,886$15.0K
GYL Financial Synergies, LLC34,000$10.0K
Dowling & Yahnke LLC12,000$4.00K
Creative Planning12,000$4.00K
All Terrain Financial Advisors, LLC15,000$4.00K
McGuire Investment Group, LLC15,000$4.00K
Blair William & Co11,200$3.00K
FMR LLC3$0